- - --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Issuer
PURSUANT to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934
Filing No. 1 for the month of April, 1999
Visible Genetics Inc.
--------------------------
(Exact name of Registrant)
700 Bay Street, Suite 1000, Toronto ON, Canada M5G 1Z6
------------------------------------------------------
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or Form 40-F
Form 20-F |X| Form 40-F |_|
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes |_| No |X|
- - --------------------------------------------------------------------------------
VISIBLE GENETICS INC.
The Company has announced that it has entered into an agreement with Roche
Diagnostics S.L. (Roche) whereby Roche will be the exclusive distributor in
Spain and Portugal of the Company's OpenGene(TM) automated DNA sequencing system
and GeneKits(TM). The agreement is for a period of three years and has
provisions that guarantee minimum annual revenues over that period to the
Company
Roche, headquartered in Basel, Switzerland, is a world leader in
research-based healthcare, with principal business in pharmaceuticals,
diagnostics, vitamins, and fragrances and flavors.
On or about April 16, 1999, the Company issued a press release with
respect to the foregoing.
The Company hereby incorporates by reference the text of this Form 6-K
(but not the Exhibit hereto) into the Company's Registration Statements on Form
F-3 (File Nos. 333-67607 and 333-68939).
Exhibit 1. Press release - "Visible Genetics Inc. and Roche Diagnostics
S.L. enter exclusive distribution and marketing agreement for VGI products in
Spain and Portugal."
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
VISIBLE GENETICS INC.
Date: April 16, 1999 By: /s/ Jeffrey D. Sherman
----------------------
Name: Jeffrey D. Sherman
Title: Vice President, Finance and C.F.O.
3